CLOROX CO Stock: price and directors' dealings · United States · SEC (Form 4)Follow the CLOROX CO share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Food & Agriculture sector, CLOROX CO has recorded 272 insider filings. Market capitalisation: €11.3bn. The latest transaction was disclosed on 24 July 2026 (Retenue fiscale). Among the most active insiders: Grier Stacey. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate CLOROX CO Hold (neutral), based on 17 analysts. Average price target: US$104.65.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,746 of 29,063 companies
FCF yld 3.3%
Earn yld 4.7%
EV/EBITDA 15.3x
ROE 164%
Gross mgn 42%
Net mgn 8.7%
Debt/EBITDA 4.7x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
All Executives272 Thresholds0 Prospectus0 Other0
Declarations 272 total
● EVP-Chief Growth & Strategy Of · Executives · 22 Jul 2026
1,681 shares @ US$95.69 0.0014% mcap 3.5% of flow Common Stock SEC:0001225208-26-006737:0
● EVP-Chief Operating Officer · Executives · 15 Jul 2026
277 shares @ US$94.75 0.0002% mcap 0.6% of flow Common Stock SEC:0001225208-26-006648:0
◆ EVP - Chief Financial Officer · Executives · 17 Jun 2026
42,118 shares Common Stock SEC:0001225208-26-006140:0
◆ EVP-Chief Operating Officer · Executives · 17 Jun 2026
42,118 shares Common Stock SEC:0001225208-26-006137:0
◆ EVP - Chief Admin Officer · Executives · 17 Jun 2026
26,324 shares Common Stock SEC:0001225208-26-006138:0
◆ EVP - Chief Legal Officer · Executives · 17 Jun 2026
26,324 shares Common Stock SEC:0001225208-26-006139:0
● EVP - Chief Financial Officer · Executives · 1 Apr 2026
244 shares @ US$103.63 2.7% of flow Common Stock SEC:0001225208-26-004373:0
● EVP-Group Pres -Hlth & Hyg · Executives · 13 Mar 2026
41 shares @ US$108.73 0.1% of flow Common Stock SEC:0001225208-26-003732:0
● EVP - Executive Chief of Staff · Executives · 13 Mar 2026
32 shares @ US$108.73 0.1% of flow Common Stock SEC:0001225208-26-003731:0
● EVP - Chief Operating Officer · Executives · 12 Dec 2025
255 shares @ US$102.83 0.2% of flow Common Stock SEC:0001225208-25-010044:0
● Chief Executive Officer · Executives · 12 Dec 2025
829 shares @ US$102.83 0.2% of flow Common Stock SEC:0001225208-25-010043:0
● VP - CAO & Corp Controller · Executives · 12 Dec 2025
24 shares @ US$102.83 0.2% of flow Common Stock SEC:0001225208-25-010042:0
● EVP - Chief Admin Officer · Executives · 12 Dec 2025
310 shares @ US$102.83 0.4% of flow Common Stock SEC:0001225208-25-010041:0
● EVP-Group Pres -Hlth & Hyg · Executives · 12 Dec 2025
133 shares @ US$102.83 0.3% of flow Common Stock SEC:0001225208-25-010040:0
● EVP - Executive Chief of Staff · Executives · 12 Dec 2025
65 shares @ US$102.83 0.1% of flow Common Stock SEC:0001225208-25-010039:0
● EVP - Chief Legal Officer · Executives · 12 Dec 2025
347 shares @ US$102.83 0.5% of flow Common Stock SEC:0001225208-25-010038:0
▲ Director · Executives · 21 Nov 2025
4,000 shares @ US$104.1291 42.8% of flow Common Stock SEC:0001225208-25-009410:0
Canonical exit: 19 Feb 2026 (T+90) ● EVP-Group Pres-Care & Conn · Executives · 3 Oct 2025
622 shares @ US$122.25 2.2% of flow Common Stock SEC:0001225208-25-008527:0
◆ EVP - Chief Financial Officer · Executives · 3 Oct 2025
2,581 shares @ US$122.25 34.7% of flow Common Stock SEC:0001225208-25-008528:0
● EVP - Chief Financial Officer · Executives · 3 Oct 2025
421 shares @ US$122.25 5.7% of flow Common Stock SEC:0001225208-25-008528:1
● EVP - Chief Financial Officer · Executives · 3 Oct 2025
893 shares @ US$122.25 12.0% of flow Common Stock SEC:0001225208-25-008528:2
◆ EVP - Chief Legal Officer · Executives · 3 Oct 2025
8,672 shares @ US$122.25 14.8% of flow Common Stock SEC:0001225208-25-008529:0
● EVP - Chief Legal Officer · Executives · 3 Oct 2025
1,904 shares @ US$122.25 3.3% of flow Common Stock SEC:0001225208-25-008529:1
● EVP - Chief Legal Officer · Executives · 3 Oct 2025
3,629 shares @ US$122.25 6.2% of flow Common Stock SEC:0001225208-25-008529:2
◆ EVP - Chief Admin Officer · Executives · 3 Oct 2025
9,293 shares @ US$122.25 13.9% of flow Common Stock SEC:0001225208-25-008530:0
25 of 272 declarations
Load more (247 remaining) 关于 CLOROX CO 高乐氏公司(NYSE: CLX)是美国领先的消费品集团,在家庭护理、消毒、卫生和部分食品相关类别中占据强势地位。高乐氏公司成立于1913年,最初名为The Electro-Alkaline Company,在加利福尼亚州奥克兰开始生产液体漂白剂,公司总部至今仍设于此。一个多世纪以来,它已从单一产品的漂白剂业务发展成为一个多元化的品牌平台,产品销往100多个市场,业务遍及约25个国家或地区。对于欧洲的法语投资者而言,高乐氏最好被视为一家防御性的美国上市消费必需品公司,在美国纽约证券交易所交易,其收入由必需的日常产品和强大的品牌忠诚度支撑。
高乐氏的产品组合涵盖多个核心业务线。其健康和保健活动包括清洁和消毒产品、洗衣添加剂和专业产品。其生活方式部门涵盖调味酱、蘸酱、调味料、酱汁、水过滤产品和天然个人护理产品。知名品牌包括Clorox、Pine-Sol、Tilex、Liquid-Plumr、Glad、Fresh Step、Kingsford、Hidden Valley、Brita和Burt’s Bees。公司还通过CloroxPro和Clorox Healthcare为专业客户提供服务。这种广泛的产品组合使高乐氏既能接触到家庭消费,也能接触到机构使用场景,同时减少了对任何单一品牌或子类别的依赖。
从竞争角度来看,高乐氏与大型全国性品牌以及自有品牌产品竞争。其优势来自于品牌资产、分销范围、品类专业知识和持续的产品创新。公司表示,约80%的销售额来自在其品类中占据第一或第二市场份额的品牌,这是特许经营实力的一个重要指标。高乐氏主要专注于其认为具有财务吸引力的中等规模品类,而不是追求广泛的商品敞口。这一策略支持了定价权和利润弹性,尽管执行情况仍受供应链状况、投入成本、零售商库存模式和营销有效性的影响。
近期发展对投资者很重要。2026年4月,高乐氏完成了对GOJO Industries(Purell制造商)的收购,将其产品组合扩展到手部卫生和健康解决方案领域。管理层称此次交易是对高乐氏消费者品牌建设能力及其B2B优势的补充。在其2026财年最新的季度更新中,公司指出业绩受到美国ERP相关库存动态的影响,同时也指出了GOJO预期带来的贡献。因此,高乐氏仍然是一个成熟但不断发展的消费必需品名称:一个具有国际影响力、悠久经营历史、强大的美国纽约证券交易所上市地位以及正在调整以抓住额外健康和卫生需求的家庭产品领导者。